IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 25,879 results that match your search.25,879 results
  • Weil Gotshal & Manges is making a late but bold entrance into the China market, opening an office in Shanghai and hiring Clifford Chance M&A and securities partner Steven Xiang to lead it.
  • Slaughter and May is to close its New York and Singapore offices. The UK firm said last month that it is shutting the outposts because they have become redundant in light of its strategic relationships with local firms.
  • Big winnings for US firms Latham & Watkins and Skadden Arps Slate Meagher & Flom are taking sides on the latest blockbuster merger to hit the US casino industry.
  • The Securities and Exchange Commission voted in July to put forward a new rule that would force most hedge fund advisers to register with the regulator.
  • Listing non-equity securities on a continuous or repeated basis under a euro medium-term note (EMTN) programme on the Vienna Stock Exchange (VSE) will be expressly permitted from October 12 2004.
  • Biotech is back in Germany Latham & Watkins and Hengeler Mueller advised on Germany's first initial public offering for a biotech company since 2001 and only the fourth IPO in the country this year. Latham advised the company, Epigenomics, on the €41.6 million deal. Hengeler Mueller acted for lead manager Morgan Stanley.
  • Is the reform-minded budget good for the economy or just for the new government's popularity, asks Sandeep Parekh
  • Detailed rules allowing China's commercial banks to issue subordinated debt will pave the way for them to improve their capital adequacy ratios, says Andrew Godwin
  • Australian courts are increasingly likely to hold corporates accountable for letters of comfort they give to local subsidiaries. Abigail Gruzman and Geoff Sutherland explain why
  • A civil lawsuit against the former chairman of the New York Stock Exchange is the latest US suit to grab the business headlines. Henry Morgenbesser discusses the case and its implications for the market